Cowen Starts Neuroderm Ltd (NDRM) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi attack on Saudi airport kills 12, over 300 wounded, authorities say
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Roth Capital Starts Neuroderm Ltd (NDRM) at Buy
December 9, 2014 7:08 AM ESTRoth Capital initiated coverage on Neuroderm Ltd (NASDAQ: NDRM) with a Buy rating and a price target of $17.50.
For an analyst ratings summary and ratings history on Neuroderm Ltd click here. For more ratings news on Neuroderm Ltd click here.
Shares of Neuroderm Ltd closed at $8.04 yesterday.
... MoreJefferies Starts Neuroderm Ltd (NDRM) at Buy, $17 PT
December 9, 2014 6:49 AM ESTJefferies initiates coverage on Neuroderm Ltd (NASDAQ: NDRM) with a Buy rating and a price target of $17.00.
Analyst Thomas Wei said, "We view NDRM's Parkinsons disease (PD) assets, ND0612L and ND0612H, as two relatively de-risked drugs among mid-stage biotech... More



